HK Stock Market Move | HUANENG POWER (00902) rises nearly 4%, signs Tiancheng Leasing framework agreement with Tiancheng Leasing
HUANENG POWER (00902) rose nearly 4%. As of press time, it was up 3.61% at HK$5.88, with a turnover of HK$109 million.
HUANENG POWER (00902) rose nearly 4%, up 3.61% as of press time, at HK$5.88, with turnover of HK$109 million.
On the news front, on October 28, HUANENG POWER issued an announcement that on October 27, 2026, the Company signed the Huaneng Group Framework Agreement with Huaneng Group, its ultimate controlling shareholder, for a term from January 1, 2027 to December 31, 2027.
The announcement stated that Tiancheng Leasing, relying on Huaneng Group's strong industry background, is a specialized leasing company dedicated to the new energy and environmental protection sectors. The terms provided by Tiancheng Leasing to the Company and its subsidiaries are on normal commercial terms and are no less favorable than those the Company and its subsidiaries could obtain from independent third parties. As a member unit of Huaneng Group, Tiancheng Leasing can design better financial leasing solutions according to the needs of the Company's project units and adopt more flexible repayment methods, enabling better matching of rental payments with project operating cash flows. In addition, the Company is a shareholder of Tiancheng Leasing, and the returns generated by Tiancheng Leasing's sound operations will bring relatively generous dividends to shareholders.
Related Articles

HK Stock Market Move | Montage Technology (06809) rose more than 9% in early trading; peer Rambus posted strong results and guidance; BofA says this is positive news for Montage

HK Stock Market Move | InnoCare Pharma (09969) rises over 4%, turns profitable in the first three quarters, with core product orelabrutinib continuing to ramp up sales.
.png)
Goldman Sachs: Raises WuXi AppTec (02359) H-share target price to HK$251, maintains "Buy" rating
HK Stock Market Move | Montage Technology (06809) rose more than 9% in early trading; peer Rambus posted strong results and guidance; BofA says this is positive news for Montage

HK Stock Market Move | InnoCare Pharma (09969) rises over 4%, turns profitable in the first three quarters, with core product orelabrutinib continuing to ramp up sales.

Goldman Sachs: Raises WuXi AppTec (02359) H-share target price to HK$251, maintains "Buy" rating
.png)





